Quisinostat
Quisinostat is a histone deacetylase inhibitor (HDAC inhibitor) that has been studied for its potential use in the treatment of various types of cancer. It is known for its ability to interfere with the function of histone deacetylases, which play a crucial role in the regulation of gene expression.
Mechanism of Action
Quisinostat works by inhibiting the activity of histone deacetylases (HDACs). HDACs are enzymes that remove acetyl groups from histone proteins, leading to a more condensed chromatin structure and reduced gene expression. By inhibiting HDACs, quisinostat causes an accumulation of acetylated histones, resulting in a more relaxed chromatin structure and increased transcription of certain genes. This can lead to the reactivation of tumor suppressor genes and the induction of cell cycle arrest, differentiation, and apoptosis in cancer cells.
Clinical Development
Quisinostat has been evaluated in several clinical trials for its efficacy and safety in treating different types of cancer, including solid tumors and hematologic malignancies. The results of these trials have shown that quisinostat has potential as a therapeutic agent, particularly in combination with other anticancer drugs.
Side Effects
As with other HDAC inhibitors, quisinostat can cause a range of side effects. Common side effects include fatigue, nausea, vomiting, and diarrhea. More serious side effects can include thrombocytopenia, neutropenia, and cardiotoxicity.
Research and Future Directions
Ongoing research is focused on understanding the full potential of quisinostat in cancer therapy, including its use in combination with other treatments such as chemotherapy, radiation therapy, and immunotherapy. Researchers are also investigating the molecular mechanisms underlying its effects and identifying biomarkers that can predict response to treatment.
See Also
References
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
